                         SEQUENCE LISTING

<110>  The Regents of the University of California
 
<120>  SUPPRESSION OF SPLA2-INTEGRIN BINDING FOR TREATING AN 
       INFLAMMATORY CONDITION OR SUPPRESSING CELL PROLIFERATION

<130>  0958428

<140>  PCT/US2015/060370
<141>  2015-11-12

<150>  US 62/079,943
<151>  2014-11-14

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic integrin beta fragment peptide

<400>  1

Leu Pro Asn Asp Gly Gln Cys His Leu Glu Asn Asn Met Tyr Thr Met 
1               5                   10                  15      


Ser His Tyr Tyr 
            20  


<210>  2
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic integrin beta fragment peptide

<400>  2

Thr Pro Asn Asp Gly Arg Cys His Leu Glu Asp Asn Leu Tyr Lys Arg 
1               5                   10                  15      


Ser Asn Glu Phe 
            20  


<210>  3
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic integrin beta fragment peptide

<400>  3

Gln Pro Asn Asp Gly Gln Cys His Val Gly Ser Asp Asn His Tyr Ser 
1               5                   10                  15      


Ala Ser Thr Thr Met 
            20      


<210>  4
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic integrin beta fragment peptide

<400>  4

Ser Arg Asn Asp Glu Arg Cys His Leu Asp Thr Thr Gly Thr Tyr Thr 
1               5                   10                  15      


Gln Tyr Arg Thr Gln 
            20      


